SevenBridge Financial Group LLC Decreases Stock Holdings in Lam Research Corporation $LRCX

SevenBridge Financial Group LLC reduced its position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 11.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 24,463 shares of the semiconductor company’s stock after selling 3,018 shares during the quarter. SevenBridge Financial Group LLC’s holdings in Lam Research were worth $3,276,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Howard Hughes Medical Institute bought a new position in Lam Research during the second quarter valued at $27,000. Sound Income Strategies LLC bought a new stake in shares of Lam Research in the 3rd quarter worth about $41,000. Tripletail Wealth Management LLC purchased a new stake in shares of Lam Research during the 3rd quarter valued at about $44,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research during the 2nd quarter valued at about $29,000. Finally, Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the 2nd quarter valued at about $30,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Stock Up 1.7%

Shares of NASDAQ LRCX opened at $218.87 on Thursday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $256.68. The firm has a 50-day simple moving average of $223.44 and a two-hundred day simple moving average of $171.66. The company has a market cap of $273.32 billion, a P/E ratio of 44.85, a PEG ratio of 2.32 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the business posted $0.91 earnings per share. The company’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is currently 21.31%.

Analysts Set New Price Targets

Several brokerages have weighed in on LRCX. Wells Fargo & Company boosted their price objective on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Bank of America raised their price objective on Lam Research from $195.00 to $245.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. Stifel Nicolaus lifted their target price on Lam Research from $250.00 to $280.00 and gave the stock a “buy” rating in a report on Thursday, January 29th. Zacks Research raised Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 20th. Finally, HSBC increased their price target on Lam Research from $181.00 to $221.00 and gave the company a “hold” rating in a report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $245.35.

Read Our Latest Stock Report on Lam Research

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Barclays raised its price target and lifted estimates for chip‑gear spending, citing stronger WFE demand that supports mid‑term upside for equipment suppliers; Barclays moved LRCX’s target to $255 (equal‑weight). Barclays Forecasts Strong Price Appreciation for Lam Research
  • Positive Sentiment: A separate analyst upgrade pushed LRCX ~1.9% higher intraday, reflecting near‑term investor appetite for large cap AI‑infrastructure and fab‑equipment names. Lam Research Trading Higher After Analyst Upgrade
  • Positive Sentiment: Lam announced a long‑term collaboration with IBM to develop processes and materials for sub‑1nm logic (including High‑NA EUV work) — a strategic move that deepens R&D ties with a major customer and supports share gains on advanced nodes. IBM and Lam Research Announce Collaboration
  • Positive Sentiment: Multiple bullish research pieces (Seeking Alpha) emphasize a supply‑constrained WFE cycle and stronger demand visibility, arguing LRCX is positioned for multi‑year growth as logic and memory capex ramps. Lam Research: Supply-Constrained WFE Cycle
  • Positive Sentiment: Index flows: Lam’s recent inclusion in large S&P indices and favorable analyst price targets (median targets well above current levels) support incremental passive and institutional demand. Lam Research jumps amid semiconductor-equipment rebound and S&P 100 addition
  • Neutral Sentiment: Short interest fell ~20.7% in February to ~26.1M shares (2.1% of float), lowering immediate squeeze risk but also reflecting position shifts among funds; days‑to‑cover ~3.0. (Data summary provided.)
  • Neutral Sentiment: Sector peers (KLA, Advanced Energy) and industry notes show broad capex momentum — helpful for Lam but also intensifies competition and execution expectations. KLA Jumps 22% in 3 Months
  • Negative Sentiment: Hazeltree reports hedge funds have ramped short bets amid geopolitical and private‑credit concerns; a risk‑off move could pressure cyclicals like LRCX if macro stress widens. Hazeltree Finds Hedge Funds Ramp Up Short Bets
  • Negative Sentiment: Insider selling has been active (multiple exec sales reported), which may concern some investors about timing of exits even though large caps often see routine option‑related sales. QuiverQuant insider & institutional activity summary

Insider Transactions at Lam Research

In related news, insider Ava Harter sold 4,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.50, for a total value of $930,000.00. Following the transaction, the insider owned 54,705 shares of the company’s stock, valued at $12,718,912.50. This trade represents a 6.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at $57,235,848. The trade was a 12.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 130,886 shares of company stock worth $29,658,802. Insiders own 0.31% of the company’s stock.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Articles

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.